Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ACAD Acadia Pharmaceuticals Inc

14,79

-0,06 (-0,40%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Acadia Pharmaceuticals Charts.

Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Acadia Pharmaceuticals Charts.

News Acadia Pharmaceuticals Inc

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freitag 17 Mai 2024 (1 Tag vor) • Business Wire

Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome
Mittwoch 15 Mai 2024 (4 Tage vor) • Business Wire

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Donnerstag 9 Mai 2024 (1 Woche vor) • Business Wire

Form 8-K - Current report
Mittwoch 8 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
Mittwoch 8 Mai 2024 (1 Woche vor) • Business Wire

Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship
Montag 29 April 2024 (3 Wochen vor) • Business Wire

Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
Mittwoch 24 April 2024 (3 Wochen vor) • Business Wire

Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada
Montag 22 April 2024 (4 Wochen vor) • Business Wire

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freitag 19 April 2024 (4 Wochen vor) • Business Wire

Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
Mittwoch 17 April 2024 (1 Monat vor) • Business Wire

Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development
Dienstag 2 April 2024 (2 Monate vor) • Business Wire

Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Montag 1 April 2024 (2 Monate vor) • Business Wire

Weitere Acadia Pharmaceuticals Inc News-Artikel

Titan Pharmaceuticals

BNPP MTUSD INAV

Visioneering Technologies

Future T.I.M.E. Dividend

Vontobel Financial Produ...

SG Issuer Sg Issuer Mc M...

Realty Incomdrn

Northfield Precision Ins... (CE)

Graniteshares 3x Short P...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen